Development and validation of LC-MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS-331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika.

Vilhena LS, de Azevedo da Silva AC, Dias da Silva DM, Pinto DP, Coelho EF, de Araújo JFGM, da Silveira GPE, Pereira HM, da Silva LSFV, Estrela Marins RCE, Bortolini RG, Souza TML, Dos Santos VGV, de Assis Nascimento V, Amendoeira FC, da Fonseca LB

Open source

DOI: 10.1002/bmc.5606
Published: 2023 May
Container: Biomedical chromatography : BMC
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/bmc.5606,
  title = {Development and validation of LC-MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS-331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika.},
  author = {Vilhena LS and de Azevedo da Silva AC and Dias da Silva DM and Pinto DP and Coelho EF and de Araújo JFGM and da Silveira GPE and Pereira HM and da Silva LSFV and Estrela Marins RCE and Bortolini RG and Souza TML and Dos Santos VGV and de Assis Nascimento V and Amendoeira FC and da Fonseca LB},
  year = {2023},
  journal = {Biomedical chromatography : BMC},
  doi = {10.1002/bmc.5606},
  url = {https://doi.org/10.1002/bmc.5606}
}

RIS

TY  - JOUR
TI  - Development and validation of LC-MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS-331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika.
AU  - Vilhena LS
AU  - de Azevedo da Silva AC
AU  - Dias da Silva DM
AU  - Pinto DP
AU  - Coelho EF
AU  - de Araújo JFGM
AU  - da Silveira GPE
AU  - Pereira HM
AU  - da Silva LSFV
AU  - Estrela Marins RCE
AU  - Bortolini RG
AU  - Souza TML
AU  - Dos Santos VGV
AU  - de Assis Nascimento V
AU  - Amendoeira FC
AU  - da Fonseca LB
PY  - 2023
JO  - Biomedical chromatography : BMC
DO  - 10.1002/bmc.5606
UR  - https://doi.org/10.1002/bmc.5606
ER  -

APA

LS, V., AC, D. A. D. S., DM, D. D. S., DP, P., EF, C., JFGM, D. A., GPE, D. S., HM, P., LSFV, D. S., RCE, E. M., RG, B., TML, S., VGV, D. S., V, D. A. N., FC, A., & LB, D. F. (2023). Development and validation of LC-MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS-331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika.. Biomedical chromatography : BMC. https://doi.org/10.1002/bmc.5606

Source records

pubmed · retrieved 2026-09-26T23:14:58.156Z